Involvement of platelet‐activating factor in hepatic apoptosis and necrosis in chronic ethanol‐fed rats given endotoxin

Wiley - Tập 22 Số 5 - Trang 394-403 - 2002
Go Murohisa1, Yoshimasa Kobayashi1, T Kawasaki1, Satoshi Nakamura2, Hirotoshi Nakamura1
1Second Department of Internal Medicine, and
2Second Department of Surgery, Hamamatsu University School of Medicine, 3600 Handa-cho, Hamamatsu, Shizuoka 431-3192, Japan

Tóm tắt

Abstract: Background/Aims: Platelet‐activating factor (PAF)—a potent activator of neutrophils—plays an important role in the pathogenesis of endotoxin‐induced tissue injury. However, the role of PAF in hepatic damage during alcoholic hepatitis remains unclear. The aims of the present study were to test whether PAF contributes to hepatic injury in an animal model of alcoholic hepatitis and to investigate the involvement of the Fas‐receptor/Fas‐ligand system in this process. Methods: Male Sprague–Dawley rats were pair‐fed with Lieber–DeCarli ethanol liquid diet or isocaloric control diet for 6 weeks. Liver injury was induced by the intravenous (i.v.) injection of lipopolysaccharide (LPS) (1 mg/kg). Rats were pretreated with a specific PAF receptor antagonist (TCV‐309; 100 mg/kg i.v.) or vehicle 1 h before LPS treatment. Results: Chronic ethanol administration remarkably sensitized the rats to the effects of LPS, with resultant severe hepatocellular injury, accompanied by significant increases in serum levels of alanine aminotransferase (ALT), tumour necrosis factor (TNF)‐α and interleukin (IL)‐8 (CINC/gro). Histological examination of the damaged livers showed hepatocyte apoptosis and necrosis with extensive infiltration by neutrophils, whereas immunohistochemical studies revealed enhanced Fas‐receptor expression on hepatocytes and hepatic accumulation of neutrophils expressing Fas‐ligand. Pretreatment with the PAF receptor antagonist protected against hepatic injury, suppressing hepatocyte apoptosis and necrosis, infiltration of neutrophils, expression of Fas‐receptor and Fas‐ligand, and serum TNF‐α levels. Conclusions: Our study suggests that PAF is an important mediator of hepatic injury in the ethanol/endotoxin model of alcoholic hepatitis.

Từ khóa


Tài liệu tham khảo

10.1055/s-2007-1007346

10.1002/jlb.61.6.647

Thurman R G., 1998, Mechanisms of hepatic toxicity II: alcoholic liver injury involves activation of Kupffer cells by endotoxin, Am J Physiol, 275, G605

10.1055/s-2007-1007347

Old L J., 1985, Tumor necrosis factor (TNF), Science, 8, 232

Bradham C A, 1998, Mechanisms of hepatic toxicity I. TNF‐induced liver injury, Am J Physiol, 275, G387

Leist M, 1995, Tumor necrosis factor‐induced hepatocyte apoptosis precedes liver failure in experimental murine shock model, Am J Pathol, 146, 1220

Thornton A J, 1992, Kupffer cell‐derived cytokines induce the synthesis of a leukocyte chemotactic peptide, interleukin‐8, in human hepatoma and primary hepatocyte cultures, Hepatology, 15, 1112

10.1016/0014-5793(92)80909-Z

10.1016/0014-4800(91)90016-Q

10.1042/bj2920617

10.1007/BF02091548

10.1097/00007890-199306000-00010

10.1055/s-2007-1007154

10.1055/s-2007-1007150

Takatani Z, 1991, Platelet‐activating factor (PAF) antagonists: development of a highly potent PAF antagonist, TCV‐309, Adv Prostaglandin Thromboxane Leukot Res, 21, 943

Terashita Z, 1992, Beneficial effects of TCV‐309, a novel potent and selective platelet‐activating factor antagonist in endotoxin and anaphylactic shock in rodents, J Pharmacol Exp Ther, 260, 748

10.1016/S0168-8278(88)80488-4

10.1210/en.137.5.1938

10.1002/hep.1840090609

10.1002/hep.1840200228

10.1111/j.1440-1746.1997.tb00426.x

10.1111/acer.1998.22.s3_part1.129s

Kuipers B, 1994, Platelet‐ activating factor antagonist TCV‐309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees, J Immunol, 152, 2438, 10.4049/jimmunol.152.5.2438

10.1002/hep.510230649

10.1084/jem.166.5.1390

10.1016/S0021-9258(18)42083-2

Dubois C, 1989, Platelet‐activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors, J Immunol, 143, 964, 10.4049/jimmunol.143.3.964

Cassatella M A, 1992, IL‐8 production by human polymorphonuclear leukocytes: the chemoattractant formyl‐methionyl‐leucyl‐phenylalanine induces the gene expression and release of IL‐8 through a pertussis toxin‐sensitive pathway, J Immunol, 148, 3216, 10.4049/jimmunol.148.10.3216

Roubin R, 1986, Biosynthesis of PAF‐acether: impairment of PAF‐acether production in activated macrophages does not depend upon acetyltransferase activity, J Immunol, 136, 1796, 10.4049/jimmunol.136.5.1796

Sisson J H, 1987, Production of platelet‐activating factor by stimulated human polymorphonuclear leukocytes, J Immunol, 138, 3918, 10.4049/jimmunol.138.11.3918

10.1016/S0014-2999(99)00337-4

Maher J J., 1995, Rat hepatocytes and Kupffer cells interact to produce interleukin‐8 (CINC) in the setting of ethanol, Am J Physiol, 269, G518

10.1111/j.1440-1746.1998.tb00716.x

10.1126/science.281.5381.1305

10.4049/jimmunol.153.4.1778

10.1016/S0092-8674(00)81874-7

10.1002/hep.510270131

10.1016/S0168-8278(00)00089-1

10.1084/jem.182.5.1223

10.1111/j.1530-0277.1999.tb04121.x

10.4049/jimmunol.166.8.4949

10.1046/j.1471-4159.1998.70031035.x

10.1097/00005373-199604000-00009

10.1006/bbrc.1993.1050

10.1002/hep.510280324